|
Volumn 124, Issue 10, 2001, Pages 1897-1899
|
Gene microarrays and experimental demyelinating disease: A tool to enhance serendipity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA4 INTEGRIN ANTIBODY;
ANTIBODY;
BETA INTERFERON;
CD4 IMMUNOGLOBULIN;
COMPLEMENTARY DNA;
GAMMA INTERFERON;
GAMMA INTERFERON ANTIBODY;
GLATIRAMER;
LENERCEPT;
LIGAND;
MESSENGER RNA;
POLYADENYLATED RNA;
TUMOR NECROSIS FACTOR ANTIBODY;
UNCLASSIFIED DRUG;
ALLERGIC ENCEPHALOMYELITIS;
CLINICAL TRIAL;
DEMYELINATING DISEASE;
DNA MICROARRAY;
DRUG EFFICACY;
EDITORIAL;
EXPERIMENTAL MODEL;
EXPERIMENTATION;
GENETIC TRANSCRIPTION;
HUMAN;
MULTIPLE SCLEROSIS;
NONHUMAN;
PRIORITY JOURNAL;
RNA HYBRIDIZATION;
|
EID: 0034779341
PISSN: 00068950
EISSN: None
Source Type: Journal
DOI: 10.1093/brain/124.10.1897 Document Type: Editorial |
Times cited : (19)
|
References (12)
|